Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01870583 · ClinicalTrials.gov registry record · NA

Comparison of Surgical Skin Preps During Cesarean Deliveries

A NA study, sponsored by Montefiore Medical Center.

Completed
Registry status
NA
Development phase
1,404
Enrollment target

NCT01870583: Completed NA study, sponsored by Montefiore Medical Center.

NCT01870583 is a NA study that has completed, run by Montefiore Medical Center. The registered enrollment target is 1,404 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01870583, a NA study, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
NA
Development phase
1,404 participants
Enrollment target

Study Summary

In women that undergo non-emergency cesarean delivery, we are comparing the skin preparation solutions for best outcome of surgical site infection. The three different solutions are: Group 1: Iodine povidone based skin preparation solution. Group 2: Chlorhexidine based skin preparation solution or Group 3: Combination usage of iodine povidone and chlorhexidine based skin preparation solutions. Women are prospectively randomized to one of the three groups and followed until thier postpartum visit at 6-8 weeks following delivery.

Primary Outcome

Surgical site infection will follow CDC guidelines: A) Superficial incisional surgical site infection B) Deep incisional surgical site infection or C) Organ/space surgical site infection.

Interventions

  • DRUG Chlorhexidine
  • DRUG Iodine povidone
  • DRUG Combination iodine and chlorhexidine

Trial Details

FieldValue
Enrollment Target 1,404 participants
Start Date 2013-02
Est. Completion 2014-07
Phase NA
Montefiore Medical Center

345 total trials

What the finished NCT01870583 record still lists

NCT01870583 is an interventional study that assigns participants to a tested intervention. Its 1,404 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.

The record links to 0 conditions, and to 3 interventions - of which Chlorhexidine is the first listed.

NCT01870583 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01870583 about?

NCT01870583 is a clinical study titled "Comparison of Surgical Skin Preps During Cesarean Deliveries". In women that undergo non-emergency cesarean delivery, we are comparing the skin preparation solutions for best outcome of surgical site infection. The three different solutions are: Group 1: Iodine povidone based skin preparation solution. Group 2: Chlorhexidine based skin preparation solution or G...

What is the current status of trial NCT01870583?

This trial is currently completed. It is a NA study. The enrollment target is 1,404 participants. The study started on 2013-02. Estimated completion is 2014-07.

What interventions are being tested in trial NCT01870583?

The interventions under investigation include: Chlorhexidine (DRUG), Iodine povidone (DRUG), Combination iodine and chlorhexidine (DRUG).

Who is sponsoring clinical trial NCT01870583?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01870583's enrollment target sits among peer trials

1,404 71st of 2000 higher than 1,930 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05444582 · 1,404 participants · Phase 4

    Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start

  • NCT05992935 · 1,405 participants · Phase 1

    Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

  • NCT02205762 · 1,400 participants · Phase 2

    LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

  • NCT02445222 · 1,400 participants · Phase 3

    CAR-T Long Term Follow Up (LTFU) Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01870583, the US trial registry maintained by the National Library of Medicine. NCT01870583 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.